Medicine Ionis announces AstraZeneca’s initiation of the Phase 2b clinical study of its antisense medicine targeting PCSK9 to lower LDL-cholesterol | News Rose Blan 3 months ago …
Fitness Fitness & Organics Announces an Attractive Discount on All Orders over $100 Rose Blan 4 months ago …
Medicine Novocure Announces Strategic Alliance with NYU Grossman School of Medicine for Preclinical and Clinical Research Rose Blan 4 months ago …
